AXSM

AXSOME THERAPEUTICS INC

AXSM·05464T104·US·Common Stock·Healthcare - Biotechnology-13D/G

AXSM (AXSOME THERAPEUTICS INC) is held by 207 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($759.7M), VANGUARD PORTFOLIO MANAGEMENT LLC ($485.5M), VANGUARD CAPITAL MANAGEMENT LLC ($481M). Net institutional sentiment: Mixed.

207
Holders
(15 Elite)
$7.6B
Total Value
57% (213)
Consensus
122 buying - 91 selling
13F: Insider & Congress: Updated regularly
AXSM

Smart Money Verdict

View all
Loading verdict
Held by 207 funds
15 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jun 11, 2026 · Activists Jul 27, 2026 · Congress none

ActivistBlackRock, Inc.BlackRock, Inc.5.3%Jul 27, 2026
InsiderJRJEFFS ROGERSell $71KJun 11, 2026
InsiderJRJEFFS ROGERSell $70KJun 10, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
3.1M(-20.7%)$759.7M0.0%+125.54%
0
Decreased
2M(-3.6%)$485.5M0.0%+21.32%
0
Increased
2M(+1.4%)$481M0.0%+20.49%
32
Increased
1.7M(+28.8%)$409.2M0.0%+40.34%
39
Decreased
1.5M(-1.8%)$376.7M0.0%+67.82%
0
Decreased
967,172(-16.8%)$236.8M0.0%+141.16%
0
Increased
804,082(+68.7%)$196.8M0.0%+28.06%
45
Decreased
785,661(-20.4%)$192.3M0.0%+135.51%
0
Increased
669,478(+107.4%)$163.9M0.1%-1.55%
59
Increased
668,373(+52.4%)$163.6M0.0%+24.23%
42
Decreased
653,920(-42.9%)$160.1M0.0%+104.64%
0
Increased
604,753(+0.2%)$148M0.1%+47.45%
30
Increased
556,088(+2578.9%)$136.1M0.0%-17.42%
49
Decreased
539,407(-33.6%)$132M0.2%+33.76%
0
Decreased
482,061(-16.5%)$118M0.1%+24.86%
0
Decreased
454,682(-47.5%)$111.3M0.1%+36.94%
0
Decreased
452,491(-24.3%)$110.8M0.0%+61.59%
0
Increased
428,079(+142.8%)$104.8M0.0%+0.53%
48
Increased
426,527(+2.5%)$104.4M0.1%+60.65%
31
Increased
426,336(+27.1%)$104.4M0.1%+49.27%
37

Showing 1-20 of 222

1 / 12
AXSMAXSMAXSOME THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used